Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort | Zendy

Yuki Obayashi | Zendy; Hirotoshi Watanabe | Zendy; Takeshi Morimoto | Zendy; Ko Yamamoto | Zendy; Masahiro Natsuaki | Zendy; Takenori Domei | Zendy; Kyohei Yamaji | Zendy; Satoru Suwa | Zendy; Tsuyoshi Isawa | Zendy; Hiroki Watanabe | Zendy; Ruka Yoshida | Zendy; Hiroki Sakamoto | Zendy; Masaharu Akao | Zendy; Yoshiki Hata | Zendy; Itsuro Morishima | Zendy; Hideo Tokuyama | Zendy; Masahiro Yagi | Zendy; Hiroshi Suzuki | Zendy; Kohei Wakabayashi | Zendy; Nobuhiro Suematsu | Zendy; Tsukasa Inada | Zendy; Toshihiro Tamura | Zendy; Hideki Okayama | Zendy; Mitsuru Abe | Zendy; Kazuya Kawai | Zendy; Kōichi Nakao | Zendy; Kenji Andò | Zendy; Kengo Tanabe | Zendy; Yuji Ikari | Zendy; Yoshihiro Morino | Zendy; Kazushige Kadota | Zendy; Yutaka Furukawa | Zendy; Yoshihisa Nakagawa | Zendy; Takeshi Kimura | Zendy

Open Access

Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort

Author(s) -

Yuki Obayashi,

Hirotoshi Watanabe,

Takeshi Morimoto,

Ko Yamamoto,

Masahiro Natsuaki,

Takenori Domei,

Kyohei Yamaji,

Satoru Suwa,

Tsuyoshi Isawa,

Hiroki Watanabe,

Ruka Yoshida,

Hiroki Sakamoto,

Masaharu Akao,

Yoshiki Hata,

Itsuro Morishima,

Hideo Tokuyama,

Masahiro Yagi,

Hiroshi Suzuki,

Kohei Wakabayashi,

Nobuhiro Suematsu,

Tsukasa Inada,

Toshihiro Tamura,

Hideki Okayama,

Mitsuru Abe,

Kazuya Kawai,

Kōichi Nakao,

Kenji Andò,

Kengo Tanabe,

Yuji Ikari,

Yoshihiro Morino,

Kazushige Kadota,

Yutaka Furukawa,

Yoshihisa Nakagawa,

Takeshi Kimura

Publication year - 2022

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.122.012004

Subject(s) - medicine , clopidogrel , percutaneous coronary intervention , acute coronary syndrome , cardiology , myocardial infarction , aspirin , hazard ratio , clinical endpoint , stent , population , ticlopidine , randomized controlled trial , confidence interval , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research